Skip to main content
Equibles

REC · RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A. IN BREVE RECORDATI S.P.A. · Financials

Use REC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research REC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
53.0500 EUR 15-min delayed · Oct 7, 08:19 UTC
Rebalance outlook locked
Market Cap
10.87B EUR
Shares
204.81M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →

Browse captured authority reports and their original financial labels

Revenue
1.58B +9.1%
FY2021 Revenue FY2020–FY2021
Net Income
385.97M +8.7%
FY2021 Net Income FY2020–FY2021
Gross Margin
72.93% +1pp
FY2021 Gross Margin FY2020–FY2021
Operating Margin
31.02% -1.4pp
FY2021 Operating Margin FY2020–FY2021
Operating Cash Flow
491.65M +21.8%
FY2021 Operating Cash Flow FY2020–FY2021

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2021 FY2020
EUR 1.58B 1.45B
EUR 427.73M 406.83M
EUR 1.15B 1.04B
EUR 166.14M 146.24M
EUR 84.5M 72.79M
EUR 25.29M 25.36M
EUR 490.19M 469.02M
EUR 463.35M 455.66M
EUR 77.38M 100.63M
EUR 385.97M 354.98M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2020–FY2024: 149.69M in buybacks, 799.99M in dividends.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.